freya meds semaglutide Home | Week 6 of my semaglutide

It also encourages feelings of fullness, which can help reduce cravings and support consistent, long-term wellness as part of a balanced lifestyle

Heart palpitations during semaglutide treatment are a real concern for some patients

Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH

Wegovy (semaglutide) can now be offered to patients at risk of stroke or heart attack, under new guidance issued by the National Institute for health and Care Excellence (NICE)